Zepeng Ping
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
Papers in
-
- Circular RNAs in diseases 3
- Epigenetics and DNA Methylation 2
-
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Co-authors
- Liliang Wei (10 shared papers)Ji‐Cheng Li (13 shared papers)Tingting Jiang (12 shared papers)Dandan Xu (9 shared papers)Yanyuan Li (5 shared papers)Zhongliang Chen (8 shared papers)Jiyan Liu (4 shared papers)Changming Liu (8 shared papers)
- Journals
- Gene (2 papers)International Journal of Biological Sciences (2 papers)PROTEOMICS (2 papers)BMC Infectious Diseases (2 papers)PLoS ONE (2 papers)
- Partner nations
- China
In The Last Decade
Zepeng Ping
20 papers receiving 475 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 161
- Infectious Diseases 181
- Epidemiology 151
- Molecular Biology 262
- Immunology 60
Countries citing papers authored by Zepeng Ping
This map shows the geographic impact of Zepeng Ping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zepeng Ping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zepeng Ping more than expected).
Fields of papers citing papers by Zepeng Ping
This network shows the impact of papers produced by Zepeng Ping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zepeng Ping. The network helps show where Zepeng Ping may publish in the future.
Co-authors
The 25 scholars most cited alongside Zepeng Ping, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 115 | |
| 2 | 2013 | 69 | |
| 3 | 2014 | 61 | |
| 4 | 2016 | 51 | |
| 5 | 2015 | 45 | |
| 6 | 2015 | 24 | |
| 7 | 2014 | 20 | |
| 8 | 2015 | 16 | |
| 9 | 2021 | 14 | |
| 10 | 2015 | 14 | |
| 11 | 2014 | 13 | |
| 12 | 2016 | 12 | |
| 13 | 2013 | 7 | |
| 14 | 2023 | 4 | |
| 15 | PLAC1 Regulates the Occurrence of Fetal Growth Restriction by Inhibiting the Apoptosis of Trophoblast Cells. | 2021 | 4 |
| 16 | 2024 | 3 | |
| 17 | 2022 | 2 | |
| 18 | 2021 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2015 | 1 |
About Zepeng Ping
Zepeng Ping is a scholar working on Molecular Biology, Epidemiology, Infectious Diseases, Obstetrics and Gynecology and Cancer Research, having authored 21 papers that have together received 477 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (5 papers), Pregnancy and preeclampsia studies (5 papers), MicroRNA in disease regulation (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Circular RNAs in diseases (3 papers), Epigenetics and DNA Methylation (2 papers), Birth, Development, and Health (2 papers) and Genetic Syndromes and Imprinting (2 papers). The work is most often cited by research in Cancer Research (161 citations), Infectious Diseases (181 citations), Epidemiology (151 citations), Molecular Biology (262 citations) and Immunology (60 citations). Zepeng Ping has collaborated with scholars based in China. Frequent co-authors include Liliang Wei, Ji‐Cheng Li, Tingting Jiang, Dandan Xu, Yanyuan Li, Zhongliang Chen, Jiyan Liu, Changming Liu, Zhongjie Li and Zhifen Pan. Their work appears in journals such as Gene, International Journal of Biological Sciences, PROTEOMICS, BMC Infectious Diseases and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.